Understanding what hepatitis C is, how it spreads and how it is treated can replace fear with clarity.

Hepatitis C is one of the most common viral infections in the United States. Without treatment, hepatitis C can lead to severe health issues. Epclusa was approved to treat chronic hepatitis C by the ...

Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and ...

For a decade now, the world has had highly effective medications for hepatitis C infections. In the United States, they’ve mostly been sitting on the shelf, according to a new study. These drugs, ...

NEW YORK (AP) — New U.S. hepatitis C infections dropped slightly in 2022, a surprising improvement after more than a decade of steady increases, federal health officials said Wednesday. Experts are ...

When it comes to children's health, what you don’t see can hurt. Hepatitis C in children often flies under the radar, presenting with no symptoms until the condition becomes serious. Here's what ...

Hepatitis C is incredibly common in the U.S., but many people don't look sick at first—or even know they have it. It's not as frequently discussed as Hepatitis A and B, which we have vaccines for, but ...

Asymptomatic disease and early progression. The progression of HCV infection to cirrhosis is often asymptomatic and clinically silent. In chronic hepatitis, the correlation of biochemical liver ...

The CDC says that hepatitis C is unique from hepatitis A and B in that over half the infections are long-term (chronic), and ...

Many hepatitis infections are going undiagnosed in cancer patients, a study published in JAMA Oncology found. The study examined more than 3,000 U.S. patients who recently received a cancer diagnosis ...

NEW YORK — New U.S. hepatitis C infections dropped slightly in 2022, a surprising improvement after more than a decade of steady increases, federal health officials said Wednesday. Experts are not ...

In the wake of recent breakthroughs in the management of hepatitis C virus (HCV) infection, with several new promising medications available on the market and more being studied in clinical trials, it ...